FULC Fulcrum Therapeutics, Inc.

NASDAQ
$3.68

Fulcrum Therapeutics, Inc. (FULC) SEC Filings

Everything FULC has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

46 filings
Date Form Filing
144
8-K Acquisition Disposition · Capital Raise · Dilution · Executive Change · Investor Presentation · Material Agreement · Reg Fd
10-Q
4
4
4
4
4
4
4
4
4
4
4
4
10-Q
10-K
4/A
4
4
4
4
4
4
4
4
4
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-K/A
10-K/A
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.